Sign in

Canadian PM Justin Trudeau keen to take AstraZeneca’s Covid-19 vaccine

Ontario province’s administration has announced that those aged 40 to 54 can now register for Covid-19 vaccination. The 49-year-old Trudeau falls in that category

Published on: Apr 21, 2021, 13:24:42 IST
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

Justin Trudeau said he would prefer taking AstraZeneca’s Covid-19 vaccine after Ontario province, where the capital city of Ottawa is located, threw open its vaccination drive against the disease, making the Canadian prime minister eligible for the jab.

Canada's Prime Minister Justin Trudeau and finance minister Chrystia Freeland take part in a news conference in Ottawa, Ontario. (REUTERS)
Canada's Prime Minister Justin Trudeau and finance minister Chrystia Freeland take part in a news conference in Ottawa, Ontario. (REUTERS)

Ontario’s administration announced on Tuesday that those aged 40 to 54 can register for vaccination. The 49-year-old Trudeau falls in that category.

Trudeau insisted on getting the AZ vaccine “to convey the message to all Canadians that they should be vaccinated with the first one that is offered to them as quickly as possible”, according to a translation of a comment in French cited by CBC News.

Trudeau’s remarks came even as a third case of rare blood clots following an AZ shot was reported in Canada.

It occurred in the province of New Brunswick, where a person received the SII-manufactured Covishield vaccine in mid-March. The unnamed individual, in the 30s, has now recovered, according to authorities.

During the course of a briefing on Tuesday, Jennifer Russel, the province’s chief medical health officer, said such cases “are extremely rare”, adding that they “do happen” and they are “treatable”.

Canada has lately been seeing a degree of vaccine hesitancy over reports of rare blood clots following the use of the AZ jab. Two cases were reported earlier, in Quebec and Alberta - both linked to the version manufactured by the Serum Institute of India (SII) under the Covishield brand name.

However, Canadian health officials have consistently stressed on the safety of the vaccination drive. Health Canada tweeted recently, “Based on all the evidence available internationally to-date, Health Canada continues to consider that the benefits of the #AstraZeneca and Covishield vaccines to protect against Covid-19 outweigh the potential risks.”

Vaccine supplies continue to be haphazard in Canada, which received 13,371,462 doses in total till April 19, including 2,316,020 AZ shots of which 500,000 were Covishield.

Canada reported 7,270 new Covid-19 cases on Tuesday, taking its total number of infections to 1,139,049, which includes 23,714 deaths.

  • Anirudh Bhattacharyya
    ABOUT THE AUTHOR
    Anirudh Bhattacharyya

    Anirudh Bhattacharya is a Toronto-based commentator on North American issues, and an author. He has also worked as a journalist in New Delhi and New York spanning print, television and digital media. He tweets as @anirudhb.Read More

Get the latest World News, breaking headlines and global updates from the US, UK, Pakistan, Bangladesh, Russia and other countries. Follow major international events on Hindustan Times.